At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- Top Insights from The Scope Forward Show 2025
- Augmented Reality to Improve Ergonomics; Positive Stool Tests and Polyp Location (GI & Endoscopy News)
- Capsule Endoscopy (GI & Endoscopy News)
- Underused Method of Colorectal Endoscopic Submucosal Dissection Could Improve Outcomes (Medscape)
- OpenAI launches ChatGPT Health, partners with b.well (MobiHealthNews)
- Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions (Freenome)
- Ro Launches Wegovy® Pill Through Integration with Novo Nordisk (Ro)
- The impact of the GI physician shortage (Becker’s GI & Endoscopy)
